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Abstract
Background: The invasive potential of cancer cells is usually assessed in vitro using Matrigel as a
surrogate basement membrane. Yet cancer cell interaction with collagen I matrices is critical,
particularly for the peritoneal metastatic route undertaken by several cancer types including
ovarian. Matrix metalloprotease (MMP) activity is important to enable cells to overcome the
barrier constraints imposed by basement membranes and stromal matrices in vivo. Our objective
was to compare matrices reconstituted from collagen I and Matrigel as representative barriers for
ovarian cancer cell invasion.
Methods: The requirement of MMP activity for ovarian cancer cell penetration of Matrigel and
collagen matrices was assessed in 2D transwell and 3D spheroid culture systems.
Results:  The broad range MMP inhibitor GM6001 completely prevented cell perforation of
polymerised collagen I-coated transwell membranes. In contrast, GM6001 decreased ES-2 cell
penetration of Matrigel by only ~30% and had no effect on HEY cell Matrigel penetration. In 3D
culture, ovarian cancer cells grown as spheroids also migrated into surrounding Matrigel matrices
despite MMP blockade. In contrast, MMP activity was required for invasion into 3D matrices of
collagen I reconstituted from acid-soluble rat-tail collagen I, but not from pepsin-extracted collagen
I (Vitrogen/Purecol), which lacks telopeptide regions.
Conclusion: Matrigel does not form representative barriers to ovarian cancer cells in either 2D
or 3D culture systems. Our findings support the use of collagen I rather than Matrigel as a matrix
barrier for invasion studies to better approximate critical interactions and events associated with
peritoneal metastasis.
Background
Cancer cell invasion of tissue matrices is a fundamental
aspect of metastasis. Extracellular matrices (ECM) are gen-
erally considered to be of two types, basement membrane
and stromal/interstitial. Basement membrane matrices are
normally deposited beneath epithelia, and its compo-
nents characteristically include collagen IV, laminin, per-
lecan and nidogen, which interact to form a thin, dense,
cross-linked polymeric network with high tensile strength.
Stromal/interstitial matrices form the majority of the
body connective tissue and are composed primarily of
fibrillar collagen I that is cross-linked into a stable mesh-
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work to impart 3D structural support. As both basement
membrane and stromal matrices present a steric barrier to
cell transmigration, matrix remodelling is a necessary and
critical contributor to metastasis. Tumour cells acquire the
ability to surmount ECM barriers by expressing a range of
proteases [1], particularly members of the matrix metallo-
protease (MMP) family [2-4]. MMPs are vital for the deg-
radation of both basement membrane and stromal
matrices: the gelatinases MMP-2 and MMP-9, and trans-
membrane MMPs are critical mediators of basement
membrane remodelling [5,6], whereas the cleavage of
stromal fibrillar collagen I networks is limited to MMPs-1,
-8, -13 and the transmembrane MMPs [2].
In vitro assays are valuable for evaluating the potential role
of candidate modulators of invasive behaviour, particu-
larly in the present era of high throughput proteomic and
genomic screens which are identifying large numbers of
possible therapeutic targets. Cancer cell invasion is typi-
cally assessed in vitro using the transwell Matrigel invasion
assay. Matrigel, an extract derived from mice harbouring
Engelbreth-Holm Swarm (EHS) tumours, is rich in lam-
inin and collagen IV and is therefore used as a surrogate
basement membrane for investigating a variety of cell
behaviours, including cancer cell invasion [5,7]. For inva-
sion assays, a thin layer of Matrigel is coated onto a
porous membrane in Boyden or Transwell chambers and
cell penetration is assessed. As such, the assay is consid-
ered to be a reliable and valuable test to evaluate cancer
cell invasiveness [5,8-11]. In an assay similar to the
Matrigel chemoinvasion assay, transwell membranes can
be coated with collagen I to reflect cellular invasion
through the confines of stromal/interstitial matrices.
For cancers such as ovarian, gastric and colon, which
metastasise within the peritoneal cavity, it is paramount
that the in vitro models adequately reflect the processes
that occur during peritoneal dissemination. Epithelial
ovarian cancers (EOC) are the most deadly of the gynae-
cological cancers and are the fifth leading cause of cancer-
related deaths in North American women [12]. The
majority of EOCs metastasize locally in a manner that
does not involve haematological transport. Ovarian
tumour cells exfoliate and are carried via peritoneal fluid
to secondary sites in the abdominal cavity where their
attachment, invasion of the submesothelial connective
tissue, and proliferation form peritoneal deposits. An
inflammatory response typically accompanies disease
progression and alters the peritoneal membrane in a man-
ner that renders it prone to cancer cell adhesion [13,14].
This further facilitates tumour dissemination such that a
self-promoting vicious cycle of metastasis ensues and
inevitably leads to impaired functioning of abdominal
organs: the obstruction and malfunctioning of the gas-
trointestinal tract are a frequent cause of morbidity from
ovarian cancer [15,16]. Devising effective strategies to pre-
vent further metastatic spread is instrumental for improv-
ing survival of patients diagnosed with advanced disease.
Important cell behaviours that contribute to ovarian can-
cer disease progression include adhesion (cell-cell and
cell-matrix), migration, and invasion [17].
The surfaces of the peritoneal cavity are covered by a layer
of mesothelial cells that function in an antiadhesive man-
ner to promote gliding of the abdominal viscera [18]. The
mesothelial layer also protects against cancer cell attach-
ment [19], as it conceals the underlying connective tissue
matrix to which tumour cells preferentially attach [19,20].
Collagen I is present in abundance beneath the peritoneal
mesothelium [21]. The collagen-binding integrins α2β1
and α3β1 mediate in vivo peritoneal metastasis of gastric
tumour cells [22,23], and their importance in this process
has been inferred for ovarian cancer cells [24-27]. Further-
more, collagen I is the preferred substrate for ovarian can-
cer cell attachment [28], and stimulation of motile
[25,29] and invasive [24] behaviour.
In these studies we compared the performance of Matrigel
and collagen I substrata as in vitro invasion matrices, both
in 2D (planar) and 3D contexts. In particular, we sought
to determine whether cell penetration of these matrices
required MMP activity, reflecting the mechanisms needed
for cancer cell invasion in vivo. We show that in contrast to
the invasion of collagen I matrices, MMP-mediated prote-
olysis is not required for cell penetration of Matrigel for
ovarian cancer cells in either 2D transwell or 3D spheroid
cell invasion systems. This contrasts with the requirement
of MMP activity for the invasion of basement membranes
in vivo, indicating the limitations of Matrigel for the eval-
uation of cancer cell invasion.
Methods
Cell culture
Four human ovarian cancer cell lines were used in these
studies: HEY and HOC-7 cells (obtained from Dr. A.
Marks), OVCA429 cells (from Dr. R. Kerbel), and ES-2
cells from American Type Culture Collection (Manassas,
VA). Cells were maintained in α-minimal essential media
(α-MEM; GIBCO) supplemented with 10% fetal bovine
serum (FBS; Cansera International Inc), 0.017% penicillin
G and 0.01% gentamycin in a humidified incubator at
37°C and 5% CO2.
Transwell matrix penetration assays
Transwells of 8 μm pore size (Costar, Corning Inc., Corn-
ing, NY) were coated with matrix, or left uncoated, for
simple migration assays. Matrigel (VWR CanLab, Missi-
sauga, ON) was diluted in ice-cold PBS to 175 μg/ml and
200 μl were added to transwells for a total of 35 μg per
well. The experiments spanned three lots of Matrigel andBMC Cancer 2008, 8:223 http://www.biomedcentral.com/1471-2407/8/223
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included both growth factor-reduced and phenol red-free
preparations. Results obtained were consistent with all
three lots Vitrogen (Cohesion, Palo Alto, CA, now sold as
Purecol) was neutralized with NaOH, diluted to 200 μg/
ml and 100 μl were added to each transwell. Matrix solu-
tions within transwells were polymerised at 37°C for 1 hr
then dried onto the transwells overnight at room temper-
ature. For examination of matrix integrity, a subset of
coated transwells were biotinylated under sterile condi-
tions, using 20 μg/ml EZ-Link Sulfo-NHS-LC-LC-Biotin
(Pierce, Rockford, IL) in 50 mM sodium bicarbonate, pH
8.3 for 2 hrs, and subsequently quenched using 50 mM
Tris-HCl, pH 7.5. Biotinylated matrices were washed 3
times prior to addition of cells. Matrices were equilibrated
in serum-free medium prior to addition of 2 × 105 cells in
medium containing 1% FBS. Outer wells initially con-
tained serum-free medium that was replaced by 10%
serum-containing medium (chemoattractant) after an ini-
tial 1–2 hrs that allowed for cell attachment. The broad-
range MMP inhibitor GM6001 (Chemicon International
Inc.) (25 μM) or the DMSO carrier (as control) were
applied to both upper and outer wells at the time of cell
seeding. Additional cells were seeded into tissue culture
dishes to verify that GM6001 treatment did not affect cell
proliferation within the duration of the assays. Following
a 24–72 hr incubation to allow cell penetration, total
invaded cells were quantified based on nucleic acid meas-
urement. Matrix integrity was assessed by confocal micro-
scopy.
Quantification of invaded cells
A simple unbiased method was used to quantify total cells
that had invaded through each transwell. Excess media
was aspirated from the transwells, and following a brief
rinse in PBS, tranwells were placed in fresh wells contain-
ing 500 μl trypsin (0.02–0.1%) so that the invaded cells
on the underside of the transwell were released into this
solution within 5 min. These solutions were microcentri-
fuged (2000 g, 5 min), and pellets containing the invaded
cells were frozen (-70°C). Quantification of invaded cells
was performed based on nucleic acid content using
CyQUANT™ dye (Molecular Probes, Inc., Eugene, OR)
according to manufacturer's instructions. For comparison,
a subset of the transwell membranes were fixed in 4%
paraformaldehyde, rinsed in PBS, and stained with DAPI
(10 min). Non-invaded cells were swabbed from the
upper side of the membrane. The membrane was
mounted and invaded cells were visualized using fluores-
cence microscopy at low magnification.
As a note, we initially used the traditional DAPI staining
microscopy-based technique to quantify invaded cells,
but observed high regional variability (non-uniform cell
penetration) regardless of whether Matrigel or collagen I
coating was used, with the majority of transmigrated cells
found in the central region. This phenomenon appears
inherent to the coating process, as it also occurs when
commercially coated transwells are used (BD biocoat
product literature) and likely results from a meniscus
effect causing higher deposition of matrix near the edges
of the transwell. The CYQUANT quantification described
above circumvented the large variability as well at the
potential for selection bias that is inherent to the tradi-
tional DAPI counting procedure.
Confocal Microscopy
For examination of matrix integrity, invasion assays were
performed using transwells coated with biotinylated
matrices. These were fixed for 30 min in 4% paraformal-
dehyde, stained with FITC-streptavidin (Molecular Probes
Inc.) diluted 1:300 in 2% BSA/PBS, mounted in anti-fade
medium (1% DABCO, [Sigma-Aldrich], 90% glycerol,
10% PBS) and visualized by confocal laser scanning
microscopy (LSM 510, Carl Zeiss Inc., Toronto, ON). In
addition to 16× and 40×, matrices were examined under
low power (10×), so larger portions of the transwell
(25%) could be visualized to ensure images recorded
under high power were truly representative.
Generally, three experiments were performed for the tran-
swell assays, with three replicates each, for each cell line.
Results were highly consistent between replicates within
each experiment, and between experiments thus the data
were pooled between the individual experiments and sub-
jected to statistical analysis to yield the results shown.
Scratch wound migration assay
Cell migration in the absence of a requirement for cell-cell
detachment was assessed using a scratch wound assay.
Monolayers of confluent cells in a 6-well plate were
wounded by scraping with a P1000 plastic pipette tip and
rinsed twice with PBS to remove floating cells. The under-
side of the dish was marked to indicate the wounded area
where the initial photos were taken. Subsequent images
were periodically recorded at the same location over the
next 18 hrs with an inverted phase microscope/PixelLink
megapixel FireWire camera (Vitana Corporation, Ottawa,
ON). Cell motility was evaluated by the reduction in dis-
tance between opposing edges of the wound.
3D spheroid invasion assays
Spheroid cell culture was performed using the hanging
drop method [30]. Briefly, 20 μl droplets of culture
medium containing 5 × 104 cells were suspended from the
lid of tissue culture dishes for 72 hours, during which time
cells clustered into compact sphere-like formations. The
spheroids were then embedded in gels. Matrigel was used
at either full concentration (~11 mg/ml) or diluted in cell
culture medium to a final concentration of 4 mg/ml. Two
collagen preparations were tested: commercially availableBMC Cancer 2008, 8:223 http://www.biomedcentral.com/1471-2407/8/223
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bovine pepsin-digested Vitrogen, and acid-extracted rat
tail collagen I (a gift from Dr. J. Sodek), both stock solu-
tions were 3 mg/ml in 0.012 N HCl. Collagen I solutions
were neutralized on ice with 0.1 N NaOH and diluted to
a final concentration of 2.1 mg/ml containing 5% FBS
using [10×] α-MEM. Matrix solutions were coated onto
the bottom of 96-well plates (75 μl) and polymerised to
form a base upon which spheroids were pipetted (1–2 per
well). The extra medium transferred was removed using
sterile blotting paper, and then an additional 100 μl of
matrix was applied to encase the spheroids. Images were
recorded initially and at 12–24 hr intervals thereafter
using an inverted phase microscope. Spheroid invasion
was qualitatively assessed as either positive or negative.
Sequential images were compared/inspected for invading
cells, which appeared as a corona around the original
spheroid that expanded with time.
Results
MMP activity is necessary for cell penetration of collagen 
I-but not Matrigel-coated transwells
Coating transwell membranes with 20 μg of polymerised
collagen I (Vitrogen) resulted in the formation of a barrier
that required MMP proteolytic activity for cancer cell pen-
etration (Fig. 1). Confocal microscopy of the coated tran-
swell membranes revealed that the polymerised collagen I
matrix solution had pooled within the transwell pores,
forming plugs. The ability of HEY, ES-2 and OVCA429
cells to clear the collagen I within pores was prevented by
the broad range MMP inhibitor GM6001 (Fig 1A). Con-
sistent with the MMP dependence for collagen I clearance,
cell invasion through the matrices was abrogated (>95%,
p < 0.05; with actual p-values of 1.6E-6, 1.9E-5 and 1.2E-
4 for HEY, ES-2 and OVCA429 cells respectively) in the
presence of GM6001 (Fig 1B). Although GM6001 usually
caused a complete abolition of cell invasion through col-
lagen I matrices, a few cells occasionally traversed the
membrane, which we speculate occurred as a result of rare
pores being incompletely blocked due to irregularities in
the transwell membrane itself (double holes) or the pres-
ence of air bubbles formed during matrix polymerisation.
When transwell membranes were coated with polymer-
ised Matrigel, the matrix concentrated within pores, form-
ing plugs in a manner similar to the collagen I (Fig. 2A).
However, in contrast to polymerized collagen I, cell perfo-
ration of the Matrigel plugs was not prevented by MMP
inhibition (Fig. 2B). The extent of HEY cell penetration
was not lowered by MMP blockade (p = 0.87; Fig. 2C)
indicating that these cells are able to transverse Matrigel
matrices in absence of MMP activity. GM6001 reduced ES-
2 cell penetration by approximately 30% (p = 0.01); a
modest effect as compared to the complete abrogation of
cell penetration through collagen I. Our preliminary stud-
ies with OVCA429 cells indicated a results similar to ES-2
Transwell collagen I invasion is MMP dependent Figure 1
Transwell collagen I invasion is MMP dependent.A, 
Confocal microscopy of biotinylated collagen I-coated tran-
swells shows HEY, ES-2 and OVCA429 cells clearance of col-
lagen I from transwell pores is abrogated by the MMP 
inhibitor GM6001. Transwell membranes coated with colla-
gen I (0.6 μg/mm2) were biotinylated prior to seeding of cells. 
Membranes were and fixed and stained with FITC-streptavi-
din at assay termination. Representative areas recorded at 
16× magnification are shownwith a magnified view of the 
transwell pores shown above. B, Collagen I transwell invasion 
was abbrogated by MMP inhibition. Invasion assays were ter-
minated at 24 hrs for HEY and 55 hrs for OVCA429 and ES-
2. Bars represent the mean ± S.E. *Significantly different from 
control (p < 0.05; 2-tailed t-test).
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Matrigel penetration does not require MMP-mediated proteolysis Figure 2
Matrigel penetration does not require MMP-mediated proteolysis. Transwell membranes coated with Matrigel (1.0 
μg/mm2) were biotinylated prior to seeding of cells. Membranes were and fixed and stained with FITC-streptavidin at assay ter-
mination. Representative areas recorded at 16× magnification are shown. A, Control membrane (no cells applied) reveals the 
Matrigel pools within and occludes the transwell pores, in a similar manner to the collagen I matrix. B, Confocal microscopy of 
biotinylated Matrigel-coated transwells indicates HEY and ES-2 cell perforation of Matrigel-plugged transwell pores is unaf-
fected by MMP blockade (GM6001). A magnified view of the transwell pores is provided above. C, Transwell Matrigel penetra-
tion was not prevented by MMP inhibition. Cell quantification was performed 55 hrs after seeding. Bars represent the mean ± 
S.E. *Significantly different from control (p < 0.05; 2-tailed t-test).
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with only modest reductions in Matrigel penetration in
response to GM6001 (data not shown).
MMP blockade can inhibit transwell migration through 
mechanisms unrelated to Matrigel coating
In comparison to HEY and ES-2 cells, the ability of HOC-
7 ovarian cancer cells to penetrate Matrigel-coated tran-
swells appeared particularly sensitive to MMP inhibition,
showing a 60% reduction in response to GM6001 (p =
0.01; Fig. 3A). However, the migration of these cells across
uncoated transwell membranes was also markedly
reduced (80% reduction) in the presence of GM6001 (p =
2.2E-5), indicating that the Matrigel coating was irrelevant
to the effect of MMP inhibition on HOC-7 transmigration
(Fig. 3A). In contrast, HEY and ES-2 cell migration across
uncoated transwell membranes was not reduced by
GM6001, nor was cell proliferation altered (data not
shown).
HOC-7 cells exhibit an epithelial morphology, grow in
tight clusters, and express E-cadherin, which is in contrast
to the fibroblast-like morphology of the N-cadherin-
expressing HEY and ES-2 cells[31]. The behaviour of these
cells lines in a scratch-wound assay indicated that whereas
HEY and ES2 cells migrate as single cells, HOC-7 cells
migrate as a sheet (Fig. 3B). We therefore postulated that
MMP inhibition might interfere with the cell-cell detach-
ment that would be required for HOC-7 cell movement
through the narrow (8 μm) transwell pores, as MMPs have
been implicated in E-cadherin cleavage [32,33]. The
migration of HOC-7 cells in a scratch wound healing
assay, which allows motility to be assessed without a need
for cell-cell detachment, was unaffected by MMP inhibi-
tion (p = 0.27; Fig 3A), providing support for this hypoth-
esis.
MMP requirement for penetration of 3D matrices is matrix 
specific
With emerging evidence that cell behaviour differs in a 3D
environment that may more accurately reflect the in vivo
situation, there is an increased use of 3D cell culture sys-
tems. We therefore assessed invasion of cells through 3D
matrices. The culture of cancer cells as spheroids may reca-
pitulate the tumour environment more accurately than
that provided by monolayer culture [34,35].
3D spheroids generated through hanging drop culture
[30] were embedded in Matrigel (~11 mg/ml) or pepsin-
digested collagen I (Vitrogen; 2.1 mg/ml final concentra-
tion) and the effect of MMP inhibition on cell invasion
was assessed. Cell migration into both Matrigel and Vitro-
gen matrices occurred despite MMP blockade. Because
pepsin-digested collagen molecules lack the telopeptide
domains required for cross-linking and matrix stability,
we also performed these experiments using acid-extracted
Inhibition of HOC-7 transwell penetration by MMP inhibition  is unrelated to the Matrigel coating Figure 3
Inhibition of HOC-7 transwell penetration by MMP 
inhibition is unrelated to the Matrigel coating.A. Effect 
of GM6001 on different modes of HOC-7 migration. B. Cell 
morphology and migration mode during scratch-wound heal-
ing assay at 10 hrs after wounding. Arrows indicate the bor-
ders of the scratch at time 0. HOC-7 cells have epithelial 
morphology and migrate as a sheet, in contrast to fibroblas-
tic-like HEY and ES-2 cells which undergo single-cell migra-
tion. Bars represent the mean ± S.E. *Significantly different 
from control (p < 0.05; 2-tailed t-test).
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collagen I, which retains intact telopeptide domains
[36,37]. In contrast to pepsin-digested collagen I, cell pen-
etration of acid-extracted collagen I was abolished by
MMP inhibition. Representative results are shown using
OVCA429 (Fig. 4) with similar results obtained for HEY
and ES-2 cells.
Discussion
Establishing in vitro invasion assays that accurately reflect
the circumstances in vivo is paramount to revealing mech-
anisms relevant to cancer metastasis. During peritoneal
metastasis, cancer cells preferentially adhere to the sub-
mesothelial ECM rather than to the mesothelial cells
[19,20]. The submesothelial connective tissue is periodi-
cally exposed at milky spots (lymphatic portals), which
are prevalent on the surface of the omentum and the sub-
diaphragmatic peritoneum. In the early stages of perito-
neal dissemination, cancer cells preferentially adhere to
the milky spots [38] likely due to exposure of the underly-
ing ECM at these sites [20,39]. Rather than effectively
eliminating tumour cells, immune cells, including those
at the milky spots, may promote tumour dissemination
through their release of inflammatory mediators [40].
With cancer progression, the mesothelium becomes com-
promised [41] due to the action of inflammatory
cytokines, including tumour necrosis factor α and inter-
leukin 1β, which cause mesothelial cell retraction [20,42].
The widespread exposure of the underlying ECM causes a
corresponding shift in the pattern of tumour cell attach-
ment such that it is no longer limited to peritoneal sur-
faces with milky spots [20]. Therefore investigating cancer
cell interaction with, and invasion of, the submesothelial
ECM is vital. Unlike the archetypal basement membrane
underlying true epithelia, consisting of a distinct collagen
IV and laminin-rich sheet, the submesothelial ECM is not
a typical basement membrane. [21]. Instead, collagen I
and FN abut the mesothelial monolayers, co-localizing
with thin deposits of collagen IV and laminin [21].
Based on its composition, Matrigel is believed to resemble
basement membrane matrices, such as that of the
endothelium, which cancer cells penetrate during haema-
tological metastasis frequently used for in vitro invasion
studies [9,10]. The attraction of the Matrigel invasion
assay is that it provides a rapid, simple method to evaluate
invasion within hours [5] as compared to the multiple
days required for tumour cell invasion of intact basement
membranes isolated from tissues. Despite the unique met-
astatic process and critical role of collagen I in peritoneal
metastasis, the in vitro invasion of ovarian, gastric and
colon cancer cells is also routinely assessed using Matrigel
matrices. However, collagen I is comparable to Matrigel in
terms of being commercially available and easy to prepare
as a transwell coating or thick (3D) gel. Collectively, our
experiments show that matrices reconstituted from
Matrigel do not adequately reflect the barrier function of
basement membranes, in either transwell or 3D invasion
systems, whereas the barrier function of stromal matrices
can be mimicked using polymerised collagen I. We show
that ovarian cancer cells can migrate through Matrigel
matrices, in the absence of MMP activity, in either thin 2D
transwell or thick 3D spheroid invasion contexts. In con-
trast, ovarian cancer cell penetration through a collagen I
barrier required MMP activity.
Matrigel differs from authentic basement membranes in
terms of the relative abundance of and interactions
between the components [43], and this may underly its
inability to mimic the barrier function of intact basement
membranes. Collagen IV is essential for basement mem-
brane tensile strength and stability, forming a cross-linked
network with which the laminin network interacts.
Whereas the components of Matrigel are chemically and
immunologically similar to the major components of
basement membranes [44], the relative abundance of and
interactions between the components differ. Most nota-
MMP requirement for spheroid cell penetration into 3D  matrices is matrix specific Figure 4
MMP requirement for spheroid cell penetration into 
3D matrices is matrix specific. Ovarian cancer cell sphe-
roids, generated by hanging drop culture, were embedded in 
polymerized matrices of A, Matrigel (undiluted, ~11 mg/ml) B, 
pepsin-extracted collagen I, (Vitrogen) and C, acid-extracted 
collagen I (2.1 mg/ml). Images reveal the spheroid edge, 
where cell penetration of matrices was apparent. An entire 
spheroid is shown in the lower inset. Cell penetration of 
Matrigel and pepsin-extracted collagen I (Vitrogen) occured 
despite MMP blockade with GM6001. In contrast, invasion of 
acid-extracted collagen 1 was prevented by MMP inhibition. 
Representative results are shown using OVCA429 spheroids 
at 60, 36, and 44 hrs for Matrigel, Vitrogen and acid-
extracted collagen I, respectively.
CTRL GM6001
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B
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bly, Matrigel matrices are substantially less cross-linked
than basement membranes [43]. As it is the cross-linked
structure that imparts strength and integrity to intact base-
ment membrane matrices, it follows that Matrigel matri-
ces would have lower resistance to cell penetration and be
unable to reflect the in vivo situation.
Collagen I is arguably the most important ECM compo-
nent with which ovarian cancer cells interact during peri-
toneal dissemination. It is the preferred substrate for
adhesion and migration of ovarian cancer cells and also
stimulates their invasive behaviour. An abundant constit-
uent of the peritoneal stromal matrix that is present
directly beneath the mesothelium, collagen I is exposed to
the peritoneal cavity at milky spots and as a result of mes-
othelial retraction. The importance of tumour cell interac-
tion with collagen I in peritoneal metastasis is supported
by the fundamental role of its receptors α2β1 integrin and
α3β1 integrin [23,45,46]. Altogether, this provides strong
rationale for the use of collagen I matrices in investiga-
tions pertaining to invasive behaviour by ovarian and
other cancers that undergo peritoneal metastasis.
In 3D culture, MMP-mediated proteolysis was required
for invasion of matrices formed from acid-extracted colla-
gen I but not of matrices formed from pepsin-digested col-
lagen I (Vitrogen/Purecol). Differences in the requirement
for MMP activity for ovarian cancer cells to invade colla-
gen I matrices formed from acid-extracted rat tail collagen
versus pepsin-solubilized collagen may be attributed to
differences in the structural integrity of the reconstituted
collagen. Pepsin cleaves within the telopeptide regions of
collagen I molecules (creating atelocollagen), whereas
these domains remain intact when acid-extraction is used
for solubilization. In addition to promoting collagen I
assembly [47], intact telopeptide regions are critical to the
strength and stability of fibrillar collagen I matrices
through the provision of lysine residues required for inter-
molecular cross-link formation [36]. These covalent cross-
links prevent collagen molecules from sliding past one
another and are the basis of the tensile strength of colla-
gen fibre systems. The collagen cross-links re-establish
during reconstitution of the acid-extracted collagen I [37],
but not pepsin-digested collagen I (atelocollagen) prepa-
rations. Consequently, it is conceivable that cancer cells
should be able to migrate through the more compliant
atelocollagen matrices without the requirement for its
degradation. Interestingly, although MMP activity was not
required for cell penetration of 3D gels of atelocollagen, it
was required when the atelocollagen was dried onto tran-
swells. This affixing of collagen to the transwell mem-
brane may compensate for the lack of cross-linking,
effectively preventing fibrils from sliding past one another
as would occur in a 3D gel.
The barrier function of Matrigel was implied but not veri-
fied in the original description of the Matrigel chemoinva-
sion assay [10]. However, cell penetration of Matrigel
does not always correlate with invasiveness. Studies have
shown that normal fibroblasts are capable of passing
through Matrigel, whereas many invasive epithelial cancer
cell lines are not, and correlation between invasive poten-
tial and capacity for Matrigel penetration was found to be
lacking [48-50]. Rather, cells of mesenchymal lineage had
a superior capacity for Matrigel penetration compared to
those of epithelial origin, regardless of whether they were
malignant or had invasive potential in vivo. Moreover,
extensive migration of the cells into Matrigel occurred in
the absence of matrix degradation [48], which is consist-
ent with our findings. Therefore, the use of Matrigel as an
invasion matrix is inconsistent with the current dogma
that MMPs are important for cancer cell invasion. Con-
versely, we have found that the in vitro collagen I invasion
capacity of a panel of ovarian cancer cell lines reflected the
in vivo capacity for peritoneal tumour formation reported
by others [31].
The function of MMPs in matrix proteolysis is well estab-
lished, yet this family of proteases also has critical roles in
various additional physiological functions that include
the cleavage of cell adhesion molecules and growth fac-
tors [51]. The results obtained for HOC-7 cells emphasize
that MMP activity can influence Matrigel transmigration
(in a cell line specific manner) for reasons unrelated to
alleviation of a matrix barrier. The apparent marked
GM6001-mediated inhibition of HOC-7 Matrigel "inva-
sion" was paralleled by a comparable reduction in migra-
tion through uncoated transwells, yet HOC-7 scratch
wound migration was unaffected by MMP inhibition. It is
plausible that MMP inhibition blocks the cell-cell detach-
ment required for these cells to migrate through the nar-
row (8 μm) transwell pores because in contrast to the
fibroblast-like HEY and ES-2 cells, the HOC-7 cells have
an epithelial morphology, grow in tight clusters, express
E-cadherin [31], and migrate as a sheet. This interpreta-
tion is supported by evidence that E-cadherin cleavage is
mediated by MMPs [1,32,33].
Matrigel contains numerous growth factors (TGFβ, EGF,
FGF, PDGF, IGF [7]) that may be activated or released
from the matrix by proteolytic cleavage, including by
some MMPs. The chemotactic response to various agents
differs between cells [52], and could contribute to
observed differences in sensitivity to MMP inhibitors
between cell lines (eg. HEY versus ES-2 in this study). This
might explain why MMP inhibition has had, at best, only
a modest influence on Matrigel penetration as compared
to collagen I invasion.BMC Cancer 2008, 8:223 http://www.biomedcentral.com/1471-2407/8/223
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The importance of considering auxiliary factors involved
in the transmigration process that are unrelated to matrix
penetration has been emphasized [52], yet most studies
evaluate treatment effects for Matrigel penetration in the
absence of migration controls. Thus, without careful
examination, the requirement of MMPs for cell dissocia-
tion/migration in some cancer cells lines may have been
misinterpreted as a requirement for proteolytic degrada-
tion of matrices. In exceptional studies where migration
control experiments have been performed, treatments
tended to affect Matrigel "invasion" and migration simi-
larly (for example [53-55]). Thus, the impact on Matrigel
penetration should be considered secondary to an altered
motility unless alterations in matrix proteolysis are
demonstrable.
Our results do not preclude the possibility that cells utilize
alternative proteolytic systems for Matrigel penetration.
For example, cathepsins have been implicated in transwell
Matrigel penetration [54,56,57] by cancer cells, including
ovarian [58]. However, marked reductions in cell motility
have also been documented in response to cathepsin pro-
tease inhibition [54]. Therefore, it is unclear whether
Matrigel degradation by cathepsin proteases is a require-
ment for cell penetration per se, or whether the observed
reductions in Matrigel penetration merely reflect reduced
cell motility. Although other proteolytic systems may
influence invasion, it is widely accepted that MMP activity
is a critical aspect of tumour penetration of basement
membranes in vivo.
Recent studies suggest cancer cells can circumvent the
requirement for matrix proteolysis and migrate through
tissues by adopting an amoeboid form of movement [59-
62]. It is notable that these studies were performed in 3D
atelocollagen or Matrigel gels, not in acid-extracted colla-
gen I. Whereas channels lined with collagen I degradation
products were generated during cancer cell invasion of 3D
acid-extracted collagen I matrices, such channels were not
observed when pepsin-digested collagen was used [63].
Thus, the phenomenon of protease-independent tumour
cell invasion may be limited to those matrices with low
levels of cross-linking.
Conclusion
Invasion involves two distinct cellular processes: matrix
degradation and cell motility. In absence of a requirement
for matrix degradation, an assay primarily evaluates
motility. To qualify as a bona fide invasion assay it is criti-
cal to demonstrate a proteolytic dependence for matrix
barrier removal. Thereafter, it is imperative to demon-
strate that the inhibition of proteolytic activity does not
affect cell migration on uncoated membranes. Under
these conditions our studies indicate that the predomi-
nant behaviour evaluated in the Matrigel chemoinvasion
assay is the capacity for cell migration on laminin/colla-
gen IV and not MMP-mediated invasion that occurs
through basement membranes and stromal matrices in
vivo. In general, cell migration through Matrigel may indi-
rectly reflect some aspects of invasive potential in that cell
attachment to laminin and motility on this substratum
are correlates of metastatic potential [64,65]. However, in
contrast to carcinomas that undergo haematological
metastasis and must penetrate the vascular endothelial
basement membrane, ovarian cancer cell interaction with
basement membrane components are not likely critical
for peritoneal metastasis, as an archetypal basement
membrane does not exist beneath the peritoneal mesothe-
lium [21]. Therefore, although Matrigel provides a highly
useful, accessible extracellular matrix for the investigation
of numerous cell behaviours, its use as a surrogate base-
ment membrane to measure invasion is questionable.
Collagen I is the preferred substrate for ovarian cancer
attachment migration and invasion, is abundant beneath
the mesothelium, and can be reconstituted to form matri-
ces that provide a barrier function. Taken together, colla-
gen I rather than Matrigel should be used in studies
investigating ovarian cancer invasive behaviours to better
approximate critical interactions and events associated
with peritoneal metastasis.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
KLS performed all studies and drafted the manuscript. TJB
performed statistical analysis. TJB and MJR revised the
manuscript. All authors were involved in the conception
of the study and data interpretation. All authors have read
and approved the final manuscript.
Acknowledgements
We are grateful to Dr. Jaro Sodek for inspiring this study. This work was 
supported by the Toronto Ovarian Cancer Research Network through 
funds raised by the Toronto Fashion Show (KLS), the Canadian Institute of 
Health Research (TJB) and the Natural Sciences and Engineering Research 
Council of Canada (MJR).
References
1. Munshi HG, Stack MS: Reciprocal interactions between adhe-
sion receptor signaling and MMP regulation.  Cancer Metastasis
Rev 2006, 25(1):45-56.
2. Brinckerhoff CE, Rutter JL, Benbow U: Interstitial collagenases as
markers of tumor progression.  Clin Cancer Res 2000,
6(12):4823-4830.
3. Ellerbroek SM, Stack MS: Membrane associated matrix metallo-
proteinases in metastasis.  BioEssays 1999, 21(11):940-949.
4. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM: Matrix met-
alloproteinases: biologic activity and clinical implications.  J
Clin Oncol 2000, 18(5):1135-1149.
5. Albini A, Benelli R, Noonan DM, Brigati C: The "chemoinvasion
assay": a tool to study tumor and endothelial cell invasion of
basement membranes.  Int J Dev Biol 2004, 48(5-6):563-571.
6. Hotary K, Li XY, Allen E, Stevens SL, Weiss SJ: A cancer cell met-
alloprotease triad regulates the basement membrane trans-
migration program.  Genes Dev 2006, 20(19):2673-2686.BMC Cancer 2008, 8:223 http://www.biomedcentral.com/1471-2407/8/223
Page 10 of 11
(page number not for citation purposes)
7. Kleinman HK, Martin GR: Matrigel: basement membrane
matrix with biological activity.  Semin Cancer Biol 2005,
15(5):378-386.
8. Bartolome RA, Galvez BG, Longo N, Baleux F, Van Muijen GN,
Sanchez-Mateos P, Arroyo AG, Teixido J: Stromal cell-derived
factor-1alpha promotes melanoma cell invasion across base-
ment membranes involving stimulation of membrane-type 1
matrix metalloproteinase and Rho GTPase activities.  Cancer
Res 2004, 64(7):2534-2543.
9. Albini A: Tumor and endothelial cell invasion of basement
membranes. The matrigel chemoinvasion assay as a tool for
dissecting molecular mechanisms.  Pathol Oncol Res 1998,
4(3):230-241.
10. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA,
Kozlowski JM, McEwan RN: A rapid in vitro assay for quantitat-
ing the invasive potential of tumor cells.  Cancer Res 1987,
47(12):3239-3245.
11. Maggiora P, Lorenzato A, Fracchioli S, Costa B, Castagnaro M, Arisio
R, Katsaros D, Massobrio M, Comoglio PM, Flavia Di Renzo M: The
RON and MET oncogenes are co-expressed in human ovar-
ian carcinomas and cooperate in activating invasiveness.  Exp
Cell Res 2003, 288(2):382-389.
12. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ: Cancer statis-
tics, 2007.  CA Cancer J Clin 2007, 57(1):43-66.
13. Freedman RS, Deavers M, Liu J, Wang E: Peritoneal inflammation
- A microenvironment for Epithelial Ovarian Cancer (EOC).
J Transl Med 2004, 2(1):23.
14. Wang E, Ngalame Y, Panelli MC, Nguyen-Jackson H, Deavers M,
Mueller P, Hu W, Savary CA, Kobayashi R, Freedman RS, Marincola
FM:  Peritoneal and subperitoneal stroma may facilitate
regional spread of ovarian cancer.  Clin Cancer Res 2005,
11(1):113-122.
15. Stratton JF, Tidy JA, Paterson ME: The surgical management of
ovarian cancer.  Cancer Treat Rev 2001, 27(2):111-118.
16. Jatoi A, Podratz KC, Gill P, Hartmann LC: Pathophysiology and
palliation of inoperable bowel obstruction in patients with
ovarian cancer.  J Support Oncol 2004, 2(4):323-337.
17. Ghosh S, Wu Y, Stack MS: Ovarian cancer-associated protein-
ases.  Cancer Treatment and Research 2002, 107:331-351.
18. Melichar B, Freedman RS: Immunology of the peritoneal cavity:
relevance for host-tumor relation.  Int J Gynecol Cancer 2002,
12(1):3-17.
19. Kenny HA, Krausz T, Yamada SD, Lengyel E: Use of a novel 3D cul-
ture model to elucidate the role of mesothelial cells,fibrob-
lasts and extra-cellular matrices on adhesion and invasion of
ovarian cancer cells to the omentum.  Int J Cancer 2007,
121(7):1463.
20. Mochizuki Y, Nakanishi H, Kodera Y, Ito S, Yamamura Y, Kato T, Hibi
K, Akiyama S, Nakao A, Tatematsu M: TNF-alpha promotes pro-
gression of peritoneal metastasis as demonstrated using a
green fluorescence protein (GFP)-tagged human gastric can-
cer cell line.  Clinical & Experimental Metastasis 2004, 21(1):39-47.
21. Witz CA, Montoya-Rodriguez IA, Cho S, Centonze VE, Bonewald LF,
Schenken RS: Composition of the extracellular matrix of the
peritoneum.  J Soc Gynecol Investig 2001, 8(5):299-304.
22. Kawamura T, Endo Y, Yonemura Y, Nojima N, Fujita H, Fujimura T,
Obata T, Yamaguchi T, Sasaki T: Significance of integrin alpha2/
beta1 in peritoneal dissemination of a human gastric cancer
xenograft model.  Int J Oncol 2001, 18(4):809-815.
23. Nishimura S, Chung YS, Yashiro M, Inoue T, Sowa M: Role of alpha
2 beta 1- and alpha 3 beta 1-integrin in the peritoneal implan-
tation of scirrhous gastric carcinoma.  Br J Cancer 1996,
74(9):1406-1412.
24. Ellerbroek SM, Wu YI, Overall CM, Stack MS: Functional interplay
between type I collagen and cell surface matrix metallopro-
teinase activity.  Journal of Biological Chemistry 2001,
276(27):24833-24842.
25. Fishman DA, Kearns A, Chilukuri K, Bafetti LM, O'Toole EA, Geor-
gacopoulos J, Ravosa MJ, Stack MS: Metastatic dissemination of
human ovarian epithelial carcinoma is promoted by
alpha2beta1-integrin-mediated interaction with type I colla-
gen.  Invasion Metastasis 1998, 18(1):15-26.
26. Skubitz AP: Adhesion molecules.  Cancer Treat Res 2002,
107:305-329.
27. Shield K, Riley C, Quinn MA, Rice GE, Ackland ML, Ahmed N:
Alpha2beta1 integrin affects metastatic potential of ovarian
carcinoma spheroids by supporting disaggregation and pro-
teolysis.  J Carcinog 2007, 6:11.
28. Moser TL, Pizzo SV, Bafetti LM, Fishman DA, Stack MS: Evidence for
preferential adhesion of ovarian epithelial carcinoma cells to
type I collagen mediated by the alpha2beta1 integrin.  Interna-
tional Journal of Cancer 1996, 67(5):695-701.
29. Burleson KM, Hansen LK, Skubitz AP: Ovarian carcinoma sphe-
roids disaggregate on type I collagen and invade live human
mesothelial cell monolayers.  Clin Exp Metastasis 2004,
21(8):685-697.
30. Kelm JM, Timmins NE, Brown CJ, Fussenegger M, Nielsen LK:
Method for generation of homogeneous multicellular tumor
spheroids applicable to a wide variety of cell types.  Biotechnol
Bioeng 2003, 83(2):173-180.
31. Sodek KL, Ringuette MJ, Brown TJ: MT1-MMP is the critical
determinant of matrix degradation and invasion by ovarian
cancer cells.  Br J Cancer  2007, 97(3):358-367.
32. Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant
W, Bruyneel E, Matrisian LM, Mareel M: Release of an invasion
promoter E-cadherin fragment by matrilysin and strome-
lysin-1.  J Cell Sci 2001, 114(Pt 1):111-118.
33. Symowicz J, Adley BP, Gleason KJ, Johnson JJ, Ghosh S, Fishman DA,
Hudson LG, Stack MS: Engagement of collagen-binding
integrins promotes matrix metalloproteinase-9-dependent
E-cadherin ectodomain shedding in ovarian carcinoma cells.
Cancer Res 2007, 67(5):2030-2039.
34. Sutherland RM: Cell and environment interactions in tumor
microregions: the multicell spheroid model.  Science 1988,
240(4849):177-184.
35. Mueller-Klieser W: Three-dimensional cell cultures: from
molecular mechanisms to clinical applications.  Am J Physiol
1997, 273(4 Pt 1):C1109-23.
36. Helseth DL Jr., Veis A: Collagen self-assembly in vitro. Differen-
tiating specific telopeptide-dependent interactions using
selective enzyme modification and the addition of free
amino telopeptide.  J Biol Chem 1981, 256(14):7118-7128.
37. Franzblau C, Kang AH, Faris B: In vitro formation of intermo-
lecular crosslinks in chick skin collagen. II. Kinetics.  Biochem
Biophys Res Commun 1970, 40(2):437-444.
38. Hagiwara A, Takahashi T, Sawai K, Taniguchi H, Shimotsuma M,
Okano S, Sakakura C, Tsujimoto H, Osaki K, Sasaki S: Milky spots
as the implantation site for malignant cells in peritoneal dis-
semination in mice.  Cancer Res 1993, 53(3):687-692.
39. Cui L, Johkura K, Liang Y, Teng R, Ogiwara N, Okouchi Y, Asanuma
K, Sasaki K: Biodefense function of omental milky spots
through cell adhesion molecules and leukocyte proliferation.
Cell Tissue Res 2002, 310(3):321-330.
40. Krist LF, Kerremans M, Broekhuis-Fluitsma DM, Eestermans IL,
Meyer S, Beelen RH: Milky spots in the greater omentum are
predominant sites of local tumour cell proliferation and
accumulation in the peritoneal cavity.  Cancer Immunol Immu-
nother 1998, 47(4):205-212.
41. Zhang XY, Pettengell R, Nasiri N, Kalia V, Dalgleish AG, Barton DP:
Characteristics and growth patterns of human peritoneal
mesothelial cells: comparison between advanced epithelial
ovarian cancer and non-ovarian cancer sources.  J Soc Gynecol
Investig 1999, 6(6):333-340.
42. Stadlmann S, Raffeiner R, Amberger A, Margreiter R, Zeimet AG,
Abendstein B, Moser PL, Mikuz G, Klosterhalfen B, Offner FA: Dis-
ruption of the integrity of human peritoneal mesothelium by
interleukin-1beta and tumor necrosis factor-alpha.  Virchows
Archiv 2003, 443(5):678-685.
43. Kalluri R: Basement membranes: structure, assembly and
role in tumour angiogenesis.  Nat Rev Cancer 2003, 3(6):422-433.
44. Engbring JA, Kleinman HK: The basement membrane matrix in
malignancy.  J Pathol 2003, 200(4):465-470.
45. Matsuoka T, Yashiro M, Nishimura S, Inoue T, Fujihara T, Sawada T,
Kato Y, Seki S, Hirakawa-Ys Chung K: Increased expression of
alpha2beta1-integrin in the peritoneal dissemination of
human gastric carcinoma.  Int J Mol Med 2000, 5(1):21-25.
46. Takatsuki H, Komatsu S, Sano R, Takada Y, Tsuji T: Adhesion of
gastric carcinoma cells to peritoneum mediated by
alpha3beta1 integrin (VLA-3).  Cancer Res 2004 ,
64(17):6065-6070.
47. Prockop DJ, Fertala A: Inhibition of the self-assembly of colla-
gen I into fibrils with synthetic peptides. Demonstration thatPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Cancer 2008, 8:223 http://www.biomedcentral.com/1471-2407/8/223
Page 11 of 11
(page number not for citation purposes)
assembly is driven by specific binding sites on the monomers.
J Biol Chem 1998, 273(25):15598-15604.
48. Noel AC, Calle A, Emonard HP, Nusgens BV, Simar L, Foidart J,
Lapiere CM, Foidart JM: Invasion of reconstituted basement
membrane matrix is not correlated to the malignant meta-
static cell phenotype.[see comment].  Cancer Res 1991,
51(1):405-414.
49. Simon N, Noel A, Foidart JM: Evaluation of in vitro reconstituted
basement membrane assay to assess the invasiveness of
tumor cells.  Invasion Metastasis 1992, 12(3-4):156-167.
50. Mackinnon WB, Hancock R, Dyne M, Russell P, Mountford CE: Eval-
uation of an in vitro invasion assay for use on solid tissue
samples and cultured cells.  Invasion Metastasis 1992, 12(5-
6):241-252.
51. Egeblad M, Werb Z: New functions for the matrix metallopro-
teinases in cancer progression.  Nature Reviews Cancer 2002,
2(3):161-174.
52. Sieuwerts AM, Klijn JG, Foekens JA: Assessment of the invasive
potential of human gynecological tumor cell lines with the in
vitro Boyden chamber assay: influences of the ability of cells
to migrate through the filter membrane.  Clin Exp Metastasis
1997, 15(1):53-62.
53. Cheung LW, Leung PC, Wong AS: Gonadotropin-releasing hor-
mone promotes ovarian cancer cell invasiveness through c-
Jun NH2-terminal kinase-mediated activation of matrix
metalloproteinase (MMP)-2 and MMP-9.  Cancer Res 2006,
66(22):10902-10910.
54. Gondi CS, Lakka SS, Dinh DH, Olivero WC, Gujrati M, Rao JS: RNAi-
mediated inhibition of cathepsin B and uPAR leads to
decreased cell invasion, angiogenesis and tumor growth in
gliomas.  Oncogene 2004, 23(52):8486-8496.
55. Ueda J, Kajita M, Suenaga N, Fujii K, Seiki M: Sequence-specific
silencing of MT1-MMP expression suppresses tumor cell
migration and invasion: importance of MT1-MMP as a thera-
peutic target for invasive tumors.  Oncogene 2003,
22(54):8716-8722.
56. Kolkhorst V, Sturzebecher J, Wiederanders B: Inhibition of
tumour cell invasion by protease inhibitors: correlation with
the protease profile.  J Cancer Res Clin Oncol 1998,
124(11):598-606.
57. Rofstad EK, Mathiesen B, Kindem K, Galappathi K: Acidic extracel-
lular pH promotes experimental metastasis of human
melanoma cells in athymic nude mice.  Cancer Res 2006,
66(13):6699-6707.
58. Nishikawa H, Ozaki Y, Nakanishi T, Blomgren K, Tada T, Arakawa A,
Suzumori K: The role of cathepsin B and cystatin C in the
mechanisms of invasion by ovarian cancer.  Gynecol Oncol 2004,
92(3):881-886.
59. Sahai E, Marshall CJ: Differing modes of tumour cell invasion
have distinct requirements for Rho/ROCK signalling and
extracellular proteolysis.[see comment].  Nat Cell Biol 2003,
5(8):711-719.
60. Friedl P, Wolf K: Tumour-cell invasion and migration: diversity
and escape mechanisms.  Nat Rev Cancer 2003, 3(5):362-374.
61. Wolf K, Mazo I, Leung H, Engelke K, von Andrian UH, Deryugina EI,
Strongin AY, Brocker EB, Friedl P: Compensation mechanism in
tumor cell migration: mesenchymal-amoeboid transition
after blocking of pericellular proteolysis.  J Cell Biol 2003,
160(2):267-277.
62. Even-Ram S, Yamada KM: Cell migration in 3D matrix.  Curr Opin
Cell Biol 2005, 17(5):524-532.
63. Sabeh F, Ota I, Holmbeck K, Birkedal-Hansen H, Soloway P, Balbin M,
Lopez-Otin C, Shapiro S, Inada M, Krane S, Allen E, Chung D, Weiss
SJ: Tumor cell traffic through the extracellular matrix is con-
trolled by the membrane-anchored collagenase MT1-MMP.
J Cell Biol 2004, 167(4):769-781.
64. Terranova VP, Liotta LA, Russo RG, Martin GR: Role of laminin in
the attachment and metastasis of murine tumor cells.  Cancer
Res 1982, 42(6):2265-2269.
65. Givant-Horwitz V, Davidson B, Reich R: Laminin-induced signal-
ing in tumor cells.  Cancer Lett 2005, 223(1):1-10.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2407/8/223/pre
pub